CXCR4 Antagonism Has Antitumor Activity in Combination with Eribulin [Research Watch]

The CXCR4 antagonist balixafortide plus eribulin achieves responses in metastatic breast cancer.

from Cancer via ola Kala on Inoreader https://ift.tt/2KBu7u8
via IFTTT